HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuharu Kamachi Selected Research

OR-2100

1/2022Targeting DNMT1 by demethylating agent OR-2100 increases tyrosine kinase inhibitors-sensitivity and depletes leukemic stem cells in chronic myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuharu Kamachi Research Topics

Disease

5Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2022 - 01/2018
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2022 - 12/2020
3Graft vs Host Disease (Graft-Versus-Host Disease)
01/2020 - 01/2018
2Neoplasms (Cancer)
01/2022 - 01/2020
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021
1BCR-ABL Negative Atypical Chronic Myeloid Leukemia (Leukemia, Myeloid, Philadelphia Negative)
06/2020
1Rheumatoid Arthritis
06/2020
1Crohn Disease (Crohn's Disease)
01/2020
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2019
1Plasmacytoma
03/2018
1Exanthema (Rash)
01/2018

Drug/Important Bio-Agent (IBA)

3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2020
3Tyrosine Kinase InhibitorsIBA
01/2022 - 12/2020
3mogamulizumabIBA
02/2019 - 01/2018
1OR-2100IBA
01/2022
1pyrimidineIBA
01/2022
1Imatinib Mesylate (Gleevec)FDA Link
01/2022
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022
1EnzymesIBA
01/2022
1MethyltransferasesIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
12/2020
1SteroidsIBA
06/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020
1Monoclonal AntibodiesIBA
01/2019
1CC ChemokinesIBA
01/2019
1Bortezomib (Velcade)FDA Link
03/2018
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2018

Therapy/Procedure

2Therapeutics
01/2022 - 01/2020
1Transplantation
01/2022
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
01/2022
1Induction Chemotherapy
06/2020
1Stem Cell Transplantation
01/2020
1Drug Therapy (Chemotherapy)
02/2019
1Hematopoietic Stem Cell Transplantation
03/2018